Prenatal Diagnostics Co. Natera Sets Terms For $100M IPO
Venture capital-backed Natera Inc., which markets a suite of prenatal tests, set terms for a $100 million initial public offering on Monday, banking on investor appetite for the diagnostics company as...To view the full article, register now.
Already a subscriber? Click here to view full article